Aerovate Therapeutics, Inc.
AVTE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,175 | -$67,785 | -$2,518 | -$5,430 |
| Dep. & Amort. | -$179 | $226 | -$221 | $8 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,295 | $5,133 | $1,185 | $1,243 |
| Change in WC | $0 | $0 | $0 | -$6,104 |
| Other Non-Cash | -$1,065 | $25,891 | -$827 | -$764 |
| Operating Cash Flow | -$22,124 | -$36,535 | -$2,381 | -$11,047 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$57 | -$136 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$148,592 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | -$12,850 | $12,850 | $13,129 |
| Other Inv. Act. | -$59 | $0 | $0 | $0 |
| Investing Cash Flow | -$148,708 | -$12,986 | $12,850 | $13,129 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $307 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $190,608 | $0 | $247 |
| Financing Cash Flow | $0 | $190,608 | $0 | $554 |
| Forex Effect | -$4 | $0 | $0 | $0 |
| Net Chg. in Cash | -$170,836 | $176,722 | $10,469 | $2,636 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $220,942 | $44,220 | $33,751 | $31,115 |
| End Cash | $50,106 | $220,942 | $44,220 | $33,751 |
| Free Cash Flow | -$22,181 | -$36,671 | -$2,381 | -$11,047 |